Comparison of Disease-Modifying Therapies for the Management of Multiple Sclerosis: Analysis of Healthcare Resource Utilization and Relapse Rates from US Insurance Claims Data

BACKGROUND: Data on comparative healthcare resource utilization and costs associated with the newer oral disease-modifying therapies (DMTs) for managing relapsing-remitting multiple sclerosis (MS) in routine clinical practice are limited. The purpose of this study was to estimate healthcare resource...

Descripción completa

Detalles Bibliográficos
Autores principales: Nicholas, Jacqueline, Boster, Aaron, Wu, Ning, Yeh, Wei-Shi, Fay, Monica, Kendter, Jon, Huang, Ming-Yi, Lee, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5820236/
https://www.ncbi.nlm.nih.gov/pubmed/29464673
http://dx.doi.org/10.1007/s41669-017-0035-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5820236/
https://www.ncbi.nlm.nih.gov/pubmed/29464673
http://dx.doi.org/10.1007/s41669-017-0035-2

Ejemplares similares